Terukazu Tanaka

737 total citations
50 papers, 554 citations indexed

About

Terukazu Tanaka is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Terukazu Tanaka has authored 50 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Hematology. Recurrent topics in Terukazu Tanaka's work include Acute Myeloid Leukemia Research (8 papers), Virus-based gene therapy research (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Terukazu Tanaka is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Virus-based gene therapy research (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Terukazu Tanaka collaborates with scholars based in Japan, United States and Germany. Terukazu Tanaka's co-authors include Yoshitsugu Kubota, Akira Kitanaka, Toshihiko Ishida, Hiroaki Ohnishi, Jiro Takahara, Osamu Imataki, Hiroaki Dobashi, Michiaki Tokuda, Genji Yamaoka and Makoto Sato and has published in prestigious journals such as The Journal of Immunology, Oncogene and Analytical Biochemistry.

In The Last Decade

Terukazu Tanaka

48 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terukazu Tanaka Japan 14 184 144 95 92 58 50 554
Tamyra Downs United States 14 179 1.0× 128 0.9× 75 0.8× 224 2.4× 20 0.3× 19 830
Subhadeep Chakrabarti Canada 8 166 0.9× 63 0.4× 104 1.1× 24 0.3× 21 0.4× 10 573
Samuel Wyllie United States 8 129 0.7× 44 0.3× 45 0.5× 58 0.6× 55 0.9× 11 578
Laure Thuillier France 15 544 3.0× 35 0.2× 108 1.1× 25 0.3× 50 0.9× 32 896
G. Cohnen Germany 13 105 0.6× 48 0.3× 133 1.4× 50 0.5× 23 0.4× 40 462
Takeya Sato Japan 16 308 1.7× 113 0.8× 99 1.0× 20 0.2× 17 0.3× 51 707
Marie Eve Moreau Canada 8 128 0.7× 66 0.5× 107 1.1× 125 1.4× 19 0.3× 9 597
Annalaura Erroi Italy 14 190 1.0× 150 1.0× 276 2.9× 51 0.6× 7 0.1× 28 665
A R L Gear United States 14 141 0.8× 62 0.4× 59 0.6× 188 2.0× 12 0.2× 23 547
LM Pelus United States 9 317 1.7× 178 1.2× 349 3.7× 207 2.3× 11 0.2× 14 1.0k

Countries citing papers authored by Terukazu Tanaka

Since Specialization
Citations

This map shows the geographic impact of Terukazu Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terukazu Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terukazu Tanaka more than expected).

Fields of papers citing papers by Terukazu Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terukazu Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terukazu Tanaka. The network helps show where Terukazu Tanaka may publish in the future.

Co-authorship network of co-authors of Terukazu Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Terukazu Tanaka. A scholar is included among the top collaborators of Terukazu Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terukazu Tanaka. Terukazu Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohta, Yasuhiko, Akira Kitanaka, Keichiro Mihara, et al.. (2011). Expression of CD38 with intracellular enzymatic activity: a possible explanation for the insulin release induced by intracellular cADPR. Molecular and Cellular Biochemistry. 352(1-2). 293–299. 11 indexed citations
2.
Imataki, Osamu, Hiroaki Ohnishi, Genji Yamaoka, et al.. (2010). Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse. International Journal of Clinical Oncology. 15(1). 112–115. 13 indexed citations
3.
Imataki, Osamu, Yoshitsugu Kubota, Hiroaki Ohnishi, et al.. (2010). Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis. Supportive Care in Cancer. 19(10). 1657–1665. 3 indexed citations
4.
Fukumoto, Tetsuya, Yoshitsugu Kubota, Akira Kitanaka, et al.. (2009). Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells. Cellular Signalling. 21(12). 1775–1783. 11 indexed citations
5.
Imataki, Osamu, H. Ohnìshì, Yumiko Ohbayashi, et al.. (2009). Fludarabine and melphalan conditioning with tacrolimus as GVHD prophylaxis for allogeneic stem cell transplant recipients is an effective reduced-intensity combination regimen compared to the conventional regimen. International Journal of Clinical Oncology. 14(3). 197–201. 1 indexed citations
6.
Imataki, Osamu, H. Ohnìshì, Akira Kitanaka, et al.. (2008). Pancytopenia Complicated with Peripheral Neuropathy Due to Copper Deficiency: Clinical Diagnostic Review. Internal Medicine. 47(23). 2063–2065. 15 indexed citations
7.
Imataki, Osamu, H. Ohnìshì, Akira Kitanaka, et al.. (2008). Isolated extramedullary relapse presenting as autologous lymphocyte response. American Journal of Hematology. 83(6). 512–514. 2 indexed citations
8.
Kubota, Yoshitsugu, et al.. (2007). Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell lines. Cancer Letters. 260(1-2). 155–162. 8 indexed citations
9.
Kubota, Yoshitsugu, et al.. (2006). Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells. Leukemia Research. 30(11). 1391–1398. 18 indexed citations
10.
Nishiyama, Susumu, Yoshitsugu Kubota, H. Ohnìshì, et al.. (2004). Cyclosporin A inhibits the early phase of NF-κB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells. International Immunopharmacology. 5(4). 699–710. 22 indexed citations
11.
Dobashi, Hiroaki, Makoto Sato, Terukazu Tanaka, et al.. (2001). Growth Hormone Prevents Fas-Induced Apoptosis in Lymphocytes through Modulation of Bcl-2 and Caspase-3. NeuroImmunoModulation. 9(5). 256–262. 31 indexed citations
12.
Kitanaka, Akira, Toshio Suzuki, Chikako Ito, et al.. (1999). CD38-Mediated Signaling Events in Murine Pro-B Cells Expressing Human CD38 With or Without Its Cytoplasmic Domain. The Journal of Immunology. 162(4). 1952–1958. 31 indexed citations
13.
Tanaka, Terukazu, et al.. (1998). Selection of the solvent system for the preparation of poly(d,l-lactic-co-glycolic acid) microspheres containing tumor necrosis factor-alpha (TNF-α). International Journal of Pharmaceutics. 160(2). 145–156. 21 indexed citations
14.
Kubota, Yoshitsugu, Takeshi Arai, Terukazu Tanaka, et al.. (1996). Thrombopoietin Modulates Platelet Activation in Vitro through Protein‐Tyrosine Phosphorylation. Stem Cells. 14(4). 439–444. 20 indexed citations
15.
Yonekura, Hideto, et al.. (1995). Cloning of a cDNA encoding rat bone marrow stromal cell antigen 1 (BST-1) from the islets of Langerhans. Gene. 165(2). 329–330. 23 indexed citations
16.
Kotb, Malak, et al.. (1993). Preservation of the Specificity of Superantigen to T Cell Receptor Vβ Elements in the Absence of MHC Class II Molecules. Cellular Immunology. 152(2). 348–357. 8 indexed citations
17.
Tasaka, Taizo, Masami Nagai, Yoshitsugu Kubota, et al.. (1992). Acute myelocytic leukemia associated with thrombocytosis and INV 3(q21.3; q26.2) in a case of Grönbland—Strandberg syndrome. Leukemia Research. 16(12). 1187–1190. 2 indexed citations
18.
Tasaka, Taizo, Masami Nagai, Kazunori Sasaki, et al.. (1992). TRANSLOCATION (3;21)(q26–2;q22–1) FOUND IN A PATIENT WITH MYELODYSPLASTIC SYNDROME AND LONG‐TERM EXPOSURE TO ORGANIC SOLVENTS. British Journal of Haematology. 82(2). 473–475. 9 indexed citations
19.
Tanaka, Terukazu, et al.. (1987). Whisker Growth from Sodium Valproate-Synthetic Aluminum Silicate Systems. YAKUGAKU ZASSHI. 107(8). 627–633. 1 indexed citations
20.
Shibasaki, Juichiro, et al.. (1968). Drug Absorption, Metabolism, and Excretion. II. Metabolism of Bucetin (β-Hydroxybutyro-p-phenetidide) in Rabbits. Chemical and Pharmaceutical Bulletin. 16(9). 1726–1731.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamyra Downs Breakdown of academic impact, for papers by Subhadeep Chakrabarti Breakdown of academic impact, for papers by Samuel Wyllie Breakdown of academic impact, for papers by Laure Thuillier Breakdown of academic impact, for papers by G. Cohnen Breakdown of academic impact, for papers by Takeya Sato Breakdown of academic impact, for papers by Marie Eve Moreau Breakdown of academic impact, for papers by Annalaura Erroi Breakdown of academic impact, for papers by A R L Gear Breakdown of academic impact, for papers by LM Pelus
Rankless by CCL
2026